Natixis Advisors’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-24,505
Closed -$4.5M 1376
2021
Q2
$4.5M Buy
24,505
+675
+3% +$124K 0.02% 672
2021
Q1
$3.64M Sell
23,830
-22,112
-48% -$3.38M 0.02% 696
2020
Q4
$7.18M Sell
45,942
-22,857
-33% -$3.57M 0.04% 442
2020
Q3
$7.87M Buy
68,799
+3,806
+6% +$436K 0.05% 385
2020
Q2
$7.3M Buy
64,993
+24,562
+61% +$2.76M 0.05% 396
2020
Q1
$3.63M Buy
40,431
+8,894
+28% +$799K 0.03% 561
2019
Q4
$3.41M Buy
31,537
+10,262
+48% +$1.11M 0.02% 671
2019
Q3
$2.08M Sell
21,275
-5,521
-21% -$541K 0.02% 765
2019
Q2
$3.51M Buy
26,796
+2,522
+10% +$330K 0.03% 581
2019
Q1
$3.28M Buy
24,274
+3,623
+18% +$490K 0.03% 585
2018
Q4
$2.01M Sell
20,651
-3,539
-15% -$345K 0.02% 710
2018
Q3
$3.36M Buy
24,190
+41
+0.2% +$5.7K 0.03% 609
2018
Q2
$3M Buy
24,149
+578
+2% +$71.8K 0.03% 629
2018
Q1
$2.63M Buy
23,571
+4,618
+24% +$515K 0.03% 678
2017
Q4
$2.27M Sell
18,953
-308
-2% -$36.8K 0.02% 681
2017
Q3
$2.7M Buy
19,261
+2,308
+14% +$324K 0.03% 636
2017
Q2
$2.06M Buy
16,953
+3,335
+24% +$406K 0.02% 690
2017
Q1
$1.65M Buy
13,618
+808
+6% +$98K 0.02% 747
2016
Q4
$1.57M Buy
12,810
+2,760
+27% +$338K 0.02% 730
2016
Q3
$1.23M Sell
10,050
-2,145
-18% -$263K 0.02% 759
2016
Q2
$1.42M Buy
12,195
+1,194
+11% +$139K 0.02% 712
2016
Q1
$1.53M Sell
11,001
-1,713
-13% -$239K 0.02% 688
2015
Q4
$2.43M Buy
12,714
+1,827
+17% +$348K 0.04% 547
2015
Q3
$1.7M Sell
10,887
-50
-0.5% -$7.82K 0.03% 639
2015
Q2
$1.98M Sell
10,937
-16,970
-61% -$3.07M 0.03% 638
2015
Q1
$4.84M Buy
27,907
+2,520
+10% +$437K 0.08% 359
2014
Q4
$4.7M Buy
25,387
+2,392
+10% +$443K 0.09% 352
2014
Q3
$3.81M Buy
22,995
+2,108
+10% +$350K 0.08% 395
2014
Q2
$3.26M Buy
20,887
+6,382
+44% +$997K 0.05% 561
2014
Q1
$2.21M Buy
14,505
+9,309
+179% +$1.42M 0.03% 606
2013
Q4
$690K Buy
5,196
+3,274
+170% +$435K 0.01% 824
2013
Q3
$223K Buy
+1,922
New +$223K ﹤0.01% 1051